Chubb announced the launch of its enhanced MasterPackage for Life Science Companies product in the UK. This is a comprehensive first and third-party policy designed for companies which develop or provide life science products, solutions or services. The product is …
Mexico’s government could absorb some liabilities arising from unexpected side effects of COVID-19 vaccines but is not considering creating a fund to do so, a top official said. As various vaccine candidates make their way through different stages of clinical …
BRUSSELS – Who foots the bill if people in poor countries fall sick with unexpected side-effects from coronavirus vaccines? It’s not clear and that’s a big problem in the battle to beat COVID-19. The World Health Organization (WHO) has so …
The world is racing towards a vaccine in record time, stirring public concerns about safety to the extent that nine leading developers have felt compelled to issue a pledge to uphold scientific standards and testing rigor. Yet, while more than …
Specialist insurer Beazley has enhanced its life sciences insurance offering in the UK with the launch of a new policy designed to protect the sector’s small and start-up research & development-focused organizations. This follows the UK launch of Beazley’s internationally …
Beazley has launched its BioSecure policy, a life sciences proposition designed for small businesses. The coverage provides flexible insurance protection against a range of exposures in the pharma, biotech and medical device sectors. By introducing BioSecure to smaller, private enterprise …
Sompo Global Risk Solutions (GRS) has formed a new team offering insurance to clients in the life sciences industry. The GRS Life Sciences team is led by Todd Lauer who has joined Sompo GRS as senior vice president. Lauer brings …
A way to diagnose a severe neurological disorder can’t be patented as it covers a law of nature, a U.S. appeals court ruled Wednesday in a closely watched case that sought to clarify the patenting for medical diagnostic tests and …
Broker JLT Specialty USA has named John Bogan as a vice president, serving U.S. life science companies and their complex products liability, clinical trial and related risks. Bogan comes to JLT from Marsh, where since 2016 he has served as …
CNA Hardy, the London-based specialist commercial insurer, announced the appointment of David Legassick as head of Life Sciences, Technology & Cyber. Reporting to Rhonda Buege, head of Healthcare and Technology, Legassick will assume responsibility for CNA Hardy’s life science, technology …
